Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System

NCT: NCT04829357 · RECRUITING

NCT IDNCT04829357
StatusRECRUITING
Start Date2021-09-09
Completion2038-12-31
SponsorEthicon, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT ABBREVO® Continence System in women undergoing Mid-urethral sling surgery for Stress Urinary Incontinence (SUI).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑